Juan F Delgado Jimenez
Overview
Explore the profile of Juan F Delgado Jimenez including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
20
Citations
295
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Ponz de Antonio I, de Juan Baguda J, Rodriguez Chaverri A, Garcia-Cosio Carmena M, Arribas Ynsaurriaga F, Delgado Jimenez J
Rev Esp Cardiol (Engl Ed)
. 2020 Feb;
73(5):422-424.
PMID: 32061565
No abstract available.
12.
de Juan Baguda J, Delgado Jimenez J
Clin Investig Arterioscler
. 2018 Nov;
30(6):265-267.
PMID: 30449402
No abstract available.
13.
Crespo-Leiro M, Anker S, Maggioni A, Coats A, Filippatos G, Ruschitzka F, et al.
Eur J Heart Fail
. 2016 Jun;
18(6):613-25.
PMID: 27324686
Aims: The European Society of Cardiology Heart Failure Long-Term Registry (ESC-HF-LT-R) was set up with the aim of describing the clinical epidemiology and the 1-year outcomes of patients with heart...
14.
Crespo Leiro M, Delgado Jimenez J
Rev Esp Cardiol (Engl Ed)
. 2016 Jan;
69(2):234.
PMID: 26777480
No abstract available.
15.
Comin Colet J, Munoz Aguilera R, Cuenca Castillo J, Delgado Jimenez J
Rev Esp Cardiol
. 2009 Jan;
62 Suppl 1:92-100.
PMID: 19174053
This article reports on the most significant developments in the field of heart failure in the past year. Principal innovations in the management of chronic heart failure are explained, including...
16.
Munoz Aguilera R, Comin Colet J, Cuenca Castillo J, Delgado Jimenez J
Rev Esp Cardiol
. 2008 Apr;
61 Suppl 1:48-57.
PMID: 18341935
This article discusses the most important developments in heart failure reported during the last year. It contains a review of new findings on chronic heart failure, acute heart failure, cardiac...
17.
Jimenez Navarro M, Diez Martinez J, Delgado Jimenez J, Crespo Leiro M
Rev Esp Cardiol
. 2006 Mar;
59 Suppl 1:55-65.
PMID: 16540021
This article is a review of developments reported in the field of heart failure in the last year. It covers advances in epidemiology, pathophysiology and therapy, including cardiac resynchronization therapy...
18.
Lopez-Guarch C, Escribano Subias P, Tello de Meneses R, Delgado Jimenez J, Sadia Perez D, Velazquez Martin M, et al.
Rev Esp Cardiol
. 2004 Oct;
57(10):946-51.
PMID: 15469792
Introduction And Objective: Prostacyclin therapy is an effective treatment for severe pulmonary hypertension. Sildenafil, a selective phosphodiesterase type 5 inhibitor, induces selective vasodilatation of the pulmonary vessels. A synergistic effect...
19.
Escribano Subias P, Cea-Calvo L, Tello de Menesses R, Gomez Sanchez M, Delgado Jimenez J, Saenz de la Calzada C
Rev Esp Cardiol
. 2003 Aug;
56(8):818-21.
PMID: 12892628
Treatment of arterial pulmonary hypertension with epoprostenol (intravenous prostacyclin) improves survival and quality of life, but the need for an implanted central venous catheter is associated with frequent complications, that...
20.
Cea-Calvo L, Escribano Subias P, Tello de Menesses R, Lazaro Salvador M, Gomez Sanchez M, Delgado Jimenez J, et al.
Rev Esp Cardiol
. 2003 Apr;
56(4):421-5.
PMID: 12689580
Background And Objective: The treatment of pulmonary hypertension associated with infection by human immunodeficiency virus has not been well defined. Treprostinil is a prostacyclin analogue that has recently been shown...